Anti-angiogenic therapy for persistent, recurrent and metastatic cervical cancer

0Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of angiogenesis inhibitors in themanagement of persistent, recurrent and metastatic cervical cancer.

Cite

CITATION STYLE

APA

Chuai, Y., Wang, A., Li, Y., Dai, G., & Zhang, X. (2019). Anti-angiogenic therapy for persistent, recurrent and metastatic cervical cancer. Cochrane Database of Systematic Reviews, 2019(5). https://doi.org/10.1002/14651858.CD013348

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free